Incidence of Invasive Fungal Infections in Patients With Previously Untreated Acute Myeloid Leukemia Receiving Venetoclax and Azacitidine

BACKGROUND: Acute myeloid leukemia (AML) is associated with poor prognosis, particularly in elderly patients with comorbidities. Combining azacitidine (AZA) with BCL-2 inhibitor venetoclax (VEN) demonstrated significant improvement in outcomes for newly-diagnosed AML patients compared to AZA alone....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Alexander, Johnson, Tanner, Abbott, Diana, Phupitakphol, Tanit, Gutman, Jonathan A, Pollyea, Daniel A, Koullias, Yiannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547523/
https://www.ncbi.nlm.nih.gov/pubmed/36225746
http://dx.doi.org/10.1093/ofid/ofac486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547523/
https://www.ncbi.nlm.nih.gov/pubmed/36225746
http://dx.doi.org/10.1093/ofid/ofac486

Ejemplares similares